Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer

| November 7, 2017 | 0 Comments
Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer

A new study suggests that the cells in treatment-resistant tumors in women with metastatic breast cancer share important characteristics that could potentially make tumors vulnerable to therapies that otherwise might not have been considered.
See Original Article

FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer

The FDA has approved rucaparib for women with BRCA-positive advanced ovarian cancer based on findings from two small clinical trials showing that it shrank tumors.
See Original Article

Powering Off Cancer

The uncontrolled growth of cancers is dependent on altered metabolism. For example, many cancers are highly dependent on the altered metabolic reactions that occur in their mitochondria. New therapies that target these reactions are being tested.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply